Crustless bread

Crustless bread is bread without crusts. Panko is made from such a bread, which is produced by passing an electric current through the dough.[1] The British food group RHM manufactures a crustless bread targeted at children called Hovis Invisible Crust, which is produced by baking the bread at low temperature.[2] Other bread manufacturers have released crustless bread, with the crusts removed.

Crustless bread
TypeBread

Measurable nutritional loss can result from omitting crusts from bread. Bread crusts are higher in the antioxidant pronyl-lysine than the inner portion of the bread.[3] Crusts from darker breads, in particular, contain higher amounts of this antioxidant,[4] which is being researched for its potential colorectal cancer inhibitory properties.[5]

See also

References
  1. Tarté, R. (2009). Ingredients in Meat Products: Properties, Functionality and Applications. Springer. p. 282. ISBN 9780387713274. Retrieved 28 January 2015.
  2. "Hovis to launch crustless bread". Manchester Evening News. 20 July 2005. Retrieved 28 January 2015.
  3. "Bread Crust And Stuffing Rich In Healthy Antioxidants". Science Daily. 5 November 2002. Retrieved 28 January 2015.
  4. Panneerselvam, Jayabal; Aranganathan, Selvaraj; Nalini, Namasivayam (August 2009). "Inhibitory effect of bread crust antioxidant pronyl-lysine on two different categories of colonic premalignant lesions induced by 1,2-dimethylhydrazine". European Journal of Cancer Prevention. 18 (4): 291–302. doi:10.1097/CEJ.0b013e32832945a6. PMID 19417676.
  5. Panneerselvam, J; Aranganathan, S; Nalini, N (2009). "Inhibitory effect of bread crust antioxidant pronyl-lysine on two different categories of colonic premalignant lesions induced by 1,2-dimethylhydrazine". European Journal of Cancer Prevention. 18 (4): 291–302. doi:10.1097/CEJ.0b013e32832945a6. PMID 19417676.
    - Panneerselvam, Jayabal; Aranganathan, Selvaraj; Nalini, Namasivayam (2009). "Inhibitory effect of bread crust antioxidant pronyl-lysine on two different categories of colonic premalignant lesions induced by 1,2-dimethylhydrazine". European Journal of Cancer Prevention. 18 (4): 291–302. doi:10.1097/CEJ.0b013e32832945a6. PMID 19417676.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.